fbpx MMJ Phytotech's Role in the Changing Medical Cannabis Industry | Marijuana Business News | Cannabis Industry & Legalization | 420 Intel

MMJ Phytotech's Role in the Changing Medical Cannabis Industry

Legalisation and acceptance of medical cannabis as a cure or therapy for certain clinical ailments is gaining global traction.

As cities across the globe act to industrialise medical cannabis, several companies have begun to position themselves as first movers in product development and distribution.

MMJ Phytotech (ASX:MMJ) is one such company establishing itself in this space.

MMJ is developing quickly and has identified key priorities moving forward, one is to leverage its offshore operations in Australia by importing CBD capsules from Switzerland which are similar to those currently selling in Europe.

MMJ-satipharm-capsule

MMJ Managing Director Andreas Gideon told Market Eye is bullish about the Company’s Australian prospects.

“If our application is approved, this will mean that our CBD capsules will be available to Australian consumers within weeks of approval.”

In the meantime, MMJ is investigating potential partnerships with farmers, horticulturalists and Australian growing facilities...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.